UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High energy Compton spectroscopy and electronic structure of Laves phase ZrFe 2

Radiation physics and chemistry (Oxford, England : 1993), 2016-08, Vol.125, p.109-114

2016

Volltextzugriff (PDF)

High energy Compton spectroscopy and electronic structure of Laves phase ZrFe2

Radiation physics and chemistry (Oxford, England : 1993), 2016-08, Vol.125, p.109-114

2016

Volltextzugriff (PDF)

Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies

Biology of blood and marrow transplantation, 2015-12, Vol.21 (12), p.2160-2166

2015

Volltextzugriff (PDF)

Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation

Biology of blood and marrow transplantation, 2019-08, Vol.25 (8), p.1526-1535

2019

Volltextzugriff (PDF)

Population Pharmacokinetic Model Demonstrates Poor Outcomes with ATG Overexposure in Adults Undergoing Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell

Biology of blood and marrow transplantation, 2020-03, Vol.26 (3), p.S157-S157

2020

Volltextzugriff (PDF)

Successful Personalization of Propylene Glycol Free Melphalan (PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT) Using Pharmacokinetic (PK)-Directed Dosing

Biology of blood and marrow transplantation, 2020-03, Vol.26 (3), p.S154-S155

2020

Volltextzugriff (PDF)

Toxicity Analysis of Propylene Glycol-Free Melphalan (Evomela®) Compared to Propylene Glycol-Based Melphalan Hydrochloride in Autologous Hematopoietic Cell Transplantation for Multiple Myeloma

Biology of blood and marrow transplantation, 2019-03, Vol.25 (3), p.S288-S288

2019

Volltextzugriff (PDF)

More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

Biology of blood and marrow transplantation, 2018-03, Vol.24 (3), p.S330-S331

2018

Volltextzugriff (PDF)

395 - More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

Biology of blood and marrow transplantation, 2018-03, Vol.24 (3), p.S330-S331

2018

Volltextzugriff (PDF)

Effect of Melphalan Exposure in Patients with Lymphoma Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)

Biology of blood and marrow transplantation, 2020-03, Vol.26 (3), p.S230-S231

2020

Volltextzugriff (PDF)

Addition of Tocilizumab to Cyclosporine-a/ Mycophenolate Mofetil (CSA/ MMF) Graft-Vs-Host Disease (GVHD) Prophylaxis Significantly Abrogates Pre-Engraftment Syndrome (PES) & Severe Acute Gvhd after Adult Double Unit Cord Blood Transplantation (dCBT)

Biology of blood and marrow transplantation, 2020-03, Vol.26 (3), p.S30-S30

2020

Volltextzugriff (PDF)

Feasibility of and Decreased Inpatient Hospital Days for Non-Hodgkin Lymphoma (NHL) and Hodgkin Lymphoma (HL) Patients with Outpatient BEAM Using Daily Etoposide and Cytarabine and Autologous Hematopoietic Stem Cell Transplantation (AHCT)

Biology of blood and marrow transplantation, 2020-03, Vol.26 (3), p.S159-S159

2020

Volltextzugriff (PDF)

Standard ATG Dosing Results in Poorer Outcomes in Overexposed Patients after Ex vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation

Biology of blood and marrow transplantation, 2019-03, Vol.25 (8), p.1526-1535

2019

Volltextzugriff (PDF)

Empiric Anti-Thymocyte Globulin (ATG) Dosing in Ex-Vivo CD34-Selected Myeloablative Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) May Result in ATG Overexposure That Negatively Affects Outcomes

Biology of blood and marrow transplantation, 2018-03, Vol.24 (3), p.S83-S84

2018

Volltextzugriff (PDF)

71 - Empiric Anti-Thymocyte Globulin (ATG) Dosing in Ex-Vivo CD34-Selected Myeloablative Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) May Result in ATG Overexposure That Negatively Affects Outcomes

Biology of blood and marrow transplantation, 2018-03, Vol.24 (3), p.S83-S84

2018

Volltextzugriff (PDF)

Feasibility and Toxicity of Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)

Biology of blood and marrow transplantation, 2018-03, Vol.24 (3), p.S129-S130

2018

Volltextzugriff (PDF)

81 - Pharmacokinetics and Toxicities after Evomela® (Propylene Glycol Free Melphalan) with Hematopoietic Stem Cell Transplant (HCT) for Multiple Myeloma (MM), AL Amyloidosis (AL), Lymphoma, Acute Myeloid Leukemia (AML), and Myelodysplastic Syndrome (MDS)

Biology of blood and marrow transplantation, 2018-03, Vol.24 (3), p.S79-S80

2018

Volltextzugriff (PDF)

153 - Feasibility and Toxicity of Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)

Biology of blood and marrow transplantation, 2018-03, Vol.24 (3), p.S129-S130

2018

Volltextzugriff (PDF)

549 - Analysis of Cytomegalovirus (CMV) Infections in the First 180 Days in Adult Sero-Positive Cord Blood Transplantation (CBT) Recipients Reveals High Infection Rates and Treatment Burden

Biology of blood and marrow transplantation, 2018-03, Vol.24 (3), p.S379-S380

2018

Volltextzugriff (PDF)

Pharmacokinetics and Toxicities after Evomela® (Propylene Glycol Free Melphalan) with Hematopoietic Stem Cell Transplant (HCT) for Multiple Myeloma (MM), AL Amyloidosis (AL), Lymphoma, Acute Myeloid Leukemia (AML), and Myelodysplastic Syndrome (MDS)

Biology of blood and marrow transplantation, 2018-03, Vol.24 (3), p.S79-S80

2018

Volltextzugriff (PDF)

Analysis of Cytomegalovirus (CMV) Infections in the First 180 Days in Adult Sero-Positive Cord Blood Transplantation (CBT) Recipients Reveals High Infection Rates and Treatment Burden

Biology of blood and marrow transplantation, 2018-03, Vol.24 (3), p.S379-S380

2018

Volltextzugriff (PDF)

198 - Therapeutic Cyclosporine-a (CSA) Levels in the First 7 Days after Cord Blood Transplantation (CBT) Are Critical to Prevent Severe Acute Graft-Versus-Host Disease (aGVHD)

Biology of blood and marrow transplantation, 2018-03, Vol.24 (3), p.S188-S189

2018

Volltextzugriff (PDF)

Therapeutic Cyclosporine-a (CSA) Levels in the First 7 Days after Cord Blood Transplantation (CBT) Are Critical to Prevent Severe Acute Graft-Versus-Host Disease (aGVHD)

Biology of blood and marrow transplantation, 2018-03, Vol.24 (3), p.S188-S189

2018

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Kollektion

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

High energy Compton spectroscopy and electronic structure of Laves phase ZrFe 2

High energy Compton spectroscopy and electronic structure of Laves phase ZrFe2

Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies

Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation

Population Pharmacokinetic Model Demonstrates Poor Outcomes with ATG Overexposure in Adults Undergoing Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell

Successful Personalization of Propylene Glycol Free Melphalan (PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT) Using Pharmacokinetic (PK)-Directed Dosing

Toxicity Analysis of Propylene Glycol-Free Melphalan (Evomela®) Compared to Propylene Glycol-Based Melphalan Hydrochloride in Autologous Hematopoietic Cell Transplantation for Multiple Myeloma

More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

395 - More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

Effect of Melphalan Exposure in Patients with Lymphoma Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)

Addition of Tocilizumab to Cyclosporine-a/ Mycophenolate Mofetil (CSA/ MMF) Graft-Vs-Host Disease (GVHD) Prophylaxis Significantly Abrogates Pre-Engraftment Syndrome (PES) & Severe Acute Gvhd after Adult Double Unit Cord Blood Transplantation (dCBT)

Feasibility of and Decreased Inpatient Hospital Days for Non-Hodgkin Lymphoma (NHL) and Hodgkin Lymphoma (HL) Patients with Outpatient BEAM Using Daily Etoposide and Cytarabine and Autologous Hematopoietic Stem Cell Transplantation (AHCT)

Standard ATG Dosing Results in Poorer Outcomes in Overexposed Patients after Ex vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation

Empiric Anti-Thymocyte Globulin (ATG) Dosing in Ex-Vivo CD34-Selected Myeloablative Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) May Result in ATG Overexposure That Negatively Affects Outcomes

71 - Empiric Anti-Thymocyte Globulin (ATG) Dosing in Ex-Vivo CD34-Selected Myeloablative Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) May Result in ATG Overexposure That Negatively Affects Outcomes

Feasibility and Toxicity of Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)

81 - Pharmacokinetics and Toxicities after Evomela® (Propylene Glycol Free Melphalan) with Hematopoietic Stem Cell Transplant (HCT) for Multiple Myeloma (MM), AL Amyloidosis (AL), Lymphoma, Acute Myeloid Leukemia (AML), and Myelodysplastic Syndrome (MDS)

153 - Feasibility and Toxicity of Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)

549 - Analysis of Cytomegalovirus (CMV) Infections in the First 180 Days in Adult Sero-Positive Cord Blood Transplantation (CBT) Recipients Reveals High Infection Rates and Treatment Burden

Pharmacokinetics and Toxicities after Evomela® (Propylene Glycol Free Melphalan) with Hematopoietic Stem Cell Transplant (HCT) for Multiple Myeloma (MM), AL Amyloidosis (AL), Lymphoma, Acute Myeloid Leukemia (AML), and Myelodysplastic Syndrome (MDS)

Analysis of Cytomegalovirus (CMV) Infections in the First 180 Days in Adult Sero-Positive Cord Blood Transplantation (CBT) Recipients Reveals High Infection Rates and Treatment Burden

198 - Therapeutic Cyclosporine-a (CSA) Levels in the First 7 Days after Cord Blood Transplantation (CBT) Are Critical to Prevent Severe Acute Graft-Versus-Host Disease (aGVHD)

Therapeutic Cyclosporine-a (CSA) Levels in the First 7 Days after Cord Blood Transplantation (CBT) Are Critical to Prevent Severe Acute Graft-Versus-Host Disease (aGVHD)

Aktive Filter

Suchergebnisse filtern